Skip to main content
Humana Inc.
Healthcare · Healthcare Plans
Made on Aug 18, 2026
Price at call $384.31
6-month call Bear -13.6%
Target by Feb 2027 $332.00
Great value below $270.00
Model v0.6.0

Projection vs Actual (6M history + forecast)

The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change -13.6% to $332.00
Predicted High $386.50 in 2 weeks
Predicted Low $332.00 at 6 months
Max Drawdown (predicted) -13.6%

Forecast

The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded. Predicted Aug 18, 2026 12:51 am
Bear HUM trends lower to $332.00 (-13.6% from $384.31) by Feb 2027. ride-then-fade
ThesisHUM has run 109% in six months on earnings beats and risk-on tape, but valuation anchors (composite FV $306, anchored-PE $170) and cracking Medicare Advantage narrative argue for gradual mean reversion. Near-term momentum and no imminent catalyst keep price sticky, with fade emerging as MA fundamentals reassert over the window.
Invalidated ifA break above $410 on MA reimbursement upside or sustained hold above $400 through Q4 invalidates the fade thesis; conversely a break below $340 accelerates it.
Checkpointtime after the call Datewhen it gets graded Predictedthe claim: closing price Current priceactual close — fills in over time Predicted returnpredicted vs $384.31 at call Conv.brain's confidence, 1–10 Driverwhy the brain put the point here
Prediction made Aug 18, 2026 $384.31 at call The anchor — every point below is measured from this price and date.
2 weeks Sep 1, 2026 $354.68–$413.94 typical range · internal point $386.50 ±7.7% 6/10 Momentum and risk-on tape keep price sticky short-term
1 month Sep 18, 2026 $341.38–$427.24 typical range · internal point $382.00 ±11.2% 6/10 Drift lower as post-beat euphoria cools
2 months Oct 18, 2026 $372.00 -3.2% 5/10 MA narrative concerns weigh, no catalyst to defend
3 months Nov 18, 2026 $358.00 -6.8% 5/10 Value gravity pulls toward composite fair value zone
4 months Dec 18, 2026 $348.00 -9.4% 4/10 Year-end positioning trims extended winners
5 months Jan 18, 2027 $340.00 -11.5% 4/10 January MA rate chatter pressures sentiment further
6 months Feb 18, 2027 $332.00 -13.6% 3/10 Convergence toward $306 fair value continues gradually

Why ranges on the short rungs? A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here — three prompt formulations all lost to simply predicting zero — while the stock's own volatility scale (σ×√t) described those windows well. So the short rungs claim what's actually knowable: the typical travel, with earnings timing flagged where the variance will come from. The internal point calls keep being generated and graded to map where real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.

Deterministic control (v0.3 value line) targets $378.61 (-1.5%) — both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it. Brain: claude-opus-4-7.

Weaknesses

No weaknesses recorded for this run.

All inputs present, no fallbacks used — nothing to flag.

Equation Inputs

Everything feeding the v0.6.0 model — value anchors, the stock's own price behaviour, and the tunable knobs.

Value anchors (from deep analysis)

Price at call$384.31
Composite fair value$306.27
Signal-adjusted fair value$258.22
DCF fair value$394.24
Anchored-PE fair value$170.07
Buy-below (value lens)$270.00
Value net score-69
Value confidence6 / 10
Quality net score+1
Memo confidence6 / 10
Deserved value (base)
Quality tilt
Deserved value (used)
Coherence (value × quality)

Price behaviour (trailing — shapes the realism line)

Realized volatility (annualized) 1m 39.5%  3m 38.7%  6m 42.2%  
Daily σ (realism noise)2.4%
Beta vs S&P 500 1m 0.75  3m 0.34  5m 0.45  
Trailing 6-month return108.8%

Knobs (equation params)

ladderArray
llm_modelclaude-opus-4-7
max_tokens3000
control_knobsArray
Neutral band (%)5
earnings_briefv1
prompt_versionp1
control_versionv0.3.0

Version & Tech Chain

What produced this prediction — stamped on the record so versions can be compared by success rate later.
Model v0.6.0 #271041f8fcd5

Tech composition (what this version is built from)

#ProcessKindGroup
1 Synthesis valuation-synthesis deterministic final
2 Scenario Analysis scenario-valuation deterministic valuation
3 Valuation / Mispricing ext-lens-value llm extended
4 Company Quality ext-lens-quality llm extended
5 Forensic Memo (combiner) ext-forensic-memo llm extended
6 Classification company-classification llm foundation
7 Live Quote fmp-quote data market-data

Inputs used (the runs that fed this prediction)

Upstream processRanLagRun id
company-classification Aug 18, 2026 freshest HUM-20260818-002106-b0a8
ext-forensic-memo Aug 18, 2026 freshest ext-HUM-20260818-003635-982a
ext-lens-quality Aug 18, 2026 freshest ext-HUM-20260818-003635-982a
ext-lens-sentiment Aug 18, 2026 freshest ext-HUM-20260818-003635-982a
ext-lens-value Aug 18, 2026 freshest ext-HUM-20260818-003635-982a
scenario-valuation Aug 18, 2026 freshest HUM-20260818-002106-b0a8
valuation-synthesis Aug 18, 2026 freshest HUM-20260818-002106-b0a8

Inputs flagged 7d+ behind the freshest one may be stale relative to the rest of the analysis.

Saved History

2 frozen snapshots — the record we score once predictions mature.
MadeModelCallAt callTargetExp.Eval due
Aug 18, 2026 v0.6.0 Bear $384.31 $332.00 -13.6% Feb 2027 viewing
Jul 25, 2026 v0.6.0 Bull $389.32 $410.00 +5.3% Jan 2027 view

Not Yet Modeled

What this v0.6.0 forecast deliberately ignores — the work ahead, in plain sight.
  • Scenario probabilities — one path, no bull/bear split (base_prob = 1.0).
  • Intraday / sub-2-week behaviour — the first claim is at 14 days by design (EOD product).
  • Position sizing / portfolio context — the path is a price claim only.